Just-Evotec Biologics EU
Biosimilars development and manufacturing company based in Toulouse, France, acquired by Sandoz in December 2025.
- Acquired, subsidiary of Sandoz
- Toulouse, FR
Biosimilars development and manufacturing company based in Toulouse, France, acquired by Sandoz in December 2025.
Evotec provides drug development and manufacturing services across all stages.
Evotec is leading the way in drug discovery services to discover the next generation of drugs higher efficacy and probability of success.
The company offers flexible access to CRO/CDMO services across the drug discovery and development continuum.
Evotec therapeutic areas expertise and approach centers around actively exploring diverse therapeutic areas to drive innovation and create novel treatment options.
Evotec SE entered an R&D collaboration with Odyssey Therapeutics, Inc. to discover potential treatments for autoimmune and inflammatory diseases.
Evotec SE and Plectonic Biotech announced a research collaboration exploring immunotherapy for solid tumors. It combines Plectonic’s LOGIBODY technology with Evotec’s BiTco platform to address limitations of traditional T cell engager therapies.
Evotec SE announced financial results for the second quarter and first half of 2026 and confirmed its updated full-year 2026 outlook.
Evotec SE announced a Phase 1 trial of JST-018, an investigational monoclonal antibody cocktail targeting orthopoxviruses. Its subsidiary Just – Evotec Biologics developed it under the U.S. Department of War’s Accelerated Antibodies Program.
The page contains a fact sheet comparing the ICH M12 Guideline with 2020 FDA Guidance.
The page contains a fact sheet comparing the ICH M12 Guideline with the 2018 Japanese PMDA Guideline on Drug Interaction.
The page discusses the 2024 ICH M12 guideline and Cyprotex's support for DDI studies.
The company works in drug discovery and development and integrates science, AI-driven innovation, and advanced technologies.
The company publishes ethics and compliance policies in four languages.
The company collaborates on drug discovery and development through partnerships.
The company has locations across North America, Europe, and the UK.
The company offers meetings to discuss requirements.
Evotec is a global biotechnology company that advances drug discovery and development with partners.
Evotec says protecting privacy is important and that it is committed to safeguarding data and information about individuals and organizations it interacts with, including website visitors and marketing email recipients.